Melagatran, An Oral Active-Site Inhibitor of Thrombin, Prevents or Delays Formation of Electrically Induced Occlusive Thrombus in the Canine Coronary Artery-Reference-Cited by-同舟云学术

Melagatran, An Oral Active-Site Inhibitor of Thrombin, Prevents or Delays Formation of Electrically Induced Occlusive Thrombus in the Canine Coronary Artery

Published:1998-03 Issue:3 Volume:31 Page:345-351
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Mehta Jawahar L.,Chen Liying,Nichols Wilmer W.,Mattsson Christer,Gustafsson David,Saldeen Tom G.P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference28 articles.

1. Frequency of intracoronary filling defects by angiography in Angina pectoris at rest

2. Coronary Angioscopy in Patients with Unstable Angina Pectoris

3. The coronary thrombus: Its origin and fate

4. Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Constituents and Safety Pharmacology: In Vitro and In Vivo Thrombosis and Hemostasis Assays;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2022

2. In Vivo or Ex Vivo Models of Thromobis;Drug Discovery and Evaluation: Pharmacological Assays;2016

3. Proteases: Nature’s Destroyers and the Drugs that Stop Them;Pharmacy & Pharmacology International Journal;2015-11-30

4. AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice;Blood;2015-03-05

5. In Vivo or Ex Vivo Models for Testing Thrombosis and Hemostasis;Drug Discovery and Evaluation: Pharmacological Assays;2015